Siri, virtual reality, IBM Watson, remote E-detailing, Amazon, virtual patient consultations; the digital tools and technologies impacting today’s HCP are evolving at a rapid pace. How is a pharma marketer to determine which investments will flourish, and which will flop?
Join DRG Digital/Manhattan Research’s team of HCP marketing experts for an interactive workshop on when, where, and how pharma should utilize new vs. existing digital platforms to maximize the value of messaging to global physicians. This workshop will include a presentation of findings from DRG’s brand new European and global physician studies, with a group Q&A discussion.
- Learn how pharma marketers can cut through the hype of Siri, virtual reality, Amazon and more to determine which HCP engagement strategies will flourish or flop
- Determine when, where and how you should utilize new vs. existing digital platforms
- Be one of the first to receive the results of our new European and global physician studies
Jeff Wray, Director, Europe & APAC Research, DRG Digital
Jeff Greene, VP, Digital Strategy & Insights, DRG Digital